IREB2 and colonic neoplasm: Promote the stability of IREB2 protein and activate the expression of its downstream TFRC gene, resulting in intracellular Fe2+ aggregation and increased ROS level, and eventually raise colon cancer cells’ susceptibility to ferroptosis.